Donald J. Griffith insider trades
Open-market stock purchases and sales by Donald J. Griffith, Chief Financial Officer at Sonnet BioTherapeutics Holdings, Inc, from SEC Form 4 filings since Nov 9, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | — |